Oncocyte Corp CEO Joshua Riggs' 2023 pay jumps 41% to $725K
Oncocyte Corp reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Oncocyte Corp reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, four executives at Oncocyte Corp received on average a compensation package of $513K, a 52% decrease compared to previous year.
Average pay of disclosed executives at Oncocyte Corp
Joshua Riggs, Chief Executive Officer, received $725K in total, which increased by 41% compared to 2022. 47% of Riggs' compensation, or $340K, was in salary. Riggs also received $117K in bonus, $220K in option awards, as well as $48K in other compensation.
Ekkehard Schütz, Chief Scientific Officer, received a compensation package of $575K. 42% of the compensation package, or $242K, was in salary.
Anish John, Chief Financial Officer, earned $449K in 2023, a 39% decrease compared to previous year.
James Liu, Controller and Principal Accounting Officer, received $305K in 2023, which increases by 17% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 29, 2024.